# SMIM11

## Overview
SMIM11 is a gene that encodes the small integral membrane protein 11, which is categorized as a transmembrane protein. This protein is implicated in various biological processes and conditions, including its potential involvement in genetic syndromes and response to vascular injury. The gene is located on chromosome 21 and has been studied in the context of Braddock-Carey syndrome and Down syndrome, where it may play a role in the genetic and neuropathological aspects of these conditions (Braddock2016Braddock–Carey; Ling2014Functional). Additionally, SMIM11 expression is modulated in response to vascular injury, suggesting a role in inflammation and vascular smooth muscle cell behavior (Herring2017Inflammation). Despite these associations, the precise functions and mechanisms of SMIM11 remain to be fully elucidated, warranting further investigation.

## Clinical Significance
The clinical significance of the SMIM11 gene, also known as small integral membrane protein 11, is still being explored, with some studies suggesting its involvement in various conditions. In the context of Braddock-Carey syndrome (BCS), a 21q22 contiguous gene syndrome, SMIM11 is located within a significant deletion region on chromosome 21. This deletion overlaps with other genes, indicating that SMIM11 may contribute to the genetic complexity of BCS (Braddock2016Braddock–Carey).

In studies related to Down syndrome, SMIM11 has been identified as differentially expressed in the Ts1Cje mouse model, which is used to study the condition. The gene's expression levels vary across different conditions, suggesting a potential role in the neuropathology associated with Down syndrome (Ling2014Functional).

Additionally, SMIM11 has been implicated in the response to vascular injury. In a study examining carotid artery ligation, SMIM11 was found to be downregulated, indicating its involvement in the inflammatory response and vascular smooth muscle cell dedifferentiation (Herring2017Inflammation). These findings suggest that alterations in SMIM11 expression may be linked to specific pathological conditions, although further research is needed to fully understand its clinical implications.


## References


[1. (Braddock2016Braddock–Carey) Stephen R. Braddock, Sarah T. South, Joshua D. Schiffman, Maria Longhurst, Leslie R. Rowe, and John C. Carey. Braddock–carey syndrome: a 21q22 contiguous gene syndrome encompassing runx1. American Journal of Medical Genetics Part A, 170(10):2580–2586, August 2016. URL: http://dx.doi.org/10.1002/ajmg.a.37870, doi:10.1002/ajmg.a.37870. This article has 12 citations.](https://doi.org/10.1002/ajmg.a.37870)

[2. (Ling2014Functional) King-Hwa Ling, Chelsee A Hewitt, Kai-Leng Tan, Pike-See Cheah, Sharmili Vidyadaran, Mei-I Lai, Han-Chung Lee, Ken Simpson, Lavinia Hyde, Melanie A Pritchard, Gordon K Smyth, Tim Thomas, and Hamish S Scott. Functional transcriptome analysis of the postnatal brain of the ts1cje mouse model for down syndrome reveals global disruption of interferon-related molecular networks. BMC Genomics, 15(1):624, 2014. URL: http://dx.doi.org/10.1186/1471-2164-15-624, doi:10.1186/1471-2164-15-624. This article has 88 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2164-15-624)

[3. (Herring2017Inflammation) B. Paul Herring, April M. Hoggatt, Sarah L. Griffith, Jeanette N. McClintick, and Patricia J. Gallagher. Inflammation and vascular smooth muscle cell dedifferentiation following carotid artery ligation. Physiological Genomics, 49(3):115–126, March 2017. URL: http://dx.doi.org/10.1152/physiolgenomics.00095.2016, doi:10.1152/physiolgenomics.00095.2016. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1152/physiolgenomics.00095.2016)